Effect of Eicosapentaenoic Acid (EPA) on Major Cardiovascular Events in Hypercholesterolemic Patients: the Japan EPA Lipid Intervention Study (JELIS).
Phase of Trial: Phase IV
Latest Information Update: 09 Mar 2010
At a glance
- Drugs Ethyl eicosapentaenoic acid (Primary) ; Pravastatin; Simvastatin
- Indications Cardiovascular disorders; Coronary artery disease; Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms JELIS
- 12 Jan 2010 Actual end date (Nov 2004) and Actual initiation date (Nov 1996)added as reported by ClinicalTrials.gov.
- 27 Apr 2007 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History